Statin Initiation and early stroke recurrence in the POINT Trial Population
View ORCID ProfileElham Azizi, Shyam Prabhakaran, James R. Brorson
doi: https://doi.org/10.1101/2024.05.07.24307030
Elham Azizi
aDepartment of Neurology, NorthShore University Health System, Evanston, IL, USA
bDepartment of Neurology, the University of Chicago, Chicago, IL, USA
MDShyam Prabhakaran
bDepartment of Neurology, the University of Chicago, Chicago, IL, USA
MDJames R. Brorson
bDepartment of Neurology, the University of Chicago, Chicago, IL, USA
MDData Availability
All data produced in the present work are contained in the manuscript
Posted May 08, 2024.
Statin Initiation and early stroke recurrence in the POINT Trial Population
Elham Azizi, Shyam Prabhakaran, James R. Brorson
medRxiv 2024.05.07.24307030; doi: https://doi.org/10.1101/2024.05.07.24307030
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (716)
- Anesthesia (210)
- Cardiovascular Medicine (2995)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12887)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4679)
- Geriatric Medicine (429)
- Health Economics (738)
- Health Informatics (2976)
- Health Policy (1080)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (436)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4465)
- Nursing (239)
- Nutrition (655)
- Oncology (2321)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1210)
- Primary Care Research (507)
- Public and Global Health (7058)
- Radiology and Imaging (1568)
- Respiratory Medicine (930)
- Rheumatology (447)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (61)
- Transplantation (214)
- Urology (186)